Qiagen Acquires Germany's ESE for $19M

Qiagen will use ESE's portable UV and fluorescence detection devices in a wide range of point-of-care diagnostic and applied testing applications.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.